Neuroimaging in dementias

Imagem de Miniatura
Arquivos
art_STELLA_Neuroimaging_in_dementias_2012.PDF (282.54 KB)
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2012
Editora
LIPPINCOTT WILLIAMS & WILKINS
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
SOUZA, Leonardo Cruz de
LEHERICY, Stephane
DUBOIS, Bruno
SARAZIN, Marie
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CURRENT OPINION IN PSYCHIATRY, v.25, n.6, p.473-479, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose of review To critically review data on the use of neuroimaging tools in the clinical diagnostic investigation of dementias. Recent findings For many years, the use of neuroimaging tools in the evaluation of dementias has been restricted to excluding neurosurgical lesions that may account for the cognitive decline. However, modern neuroimaging extends beyond this traditional role of excluding other conditions and has a key role in the clinical investigation of Alzheimer's disease and of other degenerative cortical dementias. MRI, PET with fluorodeoxyglucose, and single-photon emission computed tomography are topographic markers of neural damage and enable the identification of specific lesional patterns that characterize Alzheimer's disease and other cortical dementias. More recently, PET amyloid markers have enabled the in-vivo assessment of amyloid load, a key feature in the physiopathology of Alzheimer's disease. Summary The combined use of neuroimaging examinations with clinical, neuropsychological, and cerebrospinal fluid markers can improve the specificity of the diagnosis of Alzheimer's disease, even at early stages of the disease. In the following years, progress in research will provide standardized and validated imaging markers of Alzheimer's disease and other dementias, which may increase their application in clinical settings.
Palavras-chave
Alzheimer's disease, dementia, neuroimaging
URI
https://observatorio.fm.usp.br/handle/OPI/4329
Referências
  1. Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006
  2. Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
  3. Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9
  4. Chincarini A, 2011, NEUROIMAGE, V58, P469, DOI 10.1016/j.neuroimage.2011.05.083
  5. de Souza LC, 2011, BRAIN, V134, P2036, DOI 10.1093/brain/awr130
  6. Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050
  7. Crutch SJ, 2012, LANCET NEUROL, V11, P170, DOI 10.1016/S1474-4422(11)70289-7
  8. Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013
  9. den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048
  10. Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008
  11. Duara R, 2008, NEUROLOGY, V71, P1986, DOI 10.1212/01.wnl.0000336925.79704.9f
  12. Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4
  13. Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3
  14. Ewers M, 2011, TRENDS NEUROSCI, V34, P430, DOI 10.1016/j.tins.2011.05.005
  15. Fleisher AS, 2011, ARCH NEUROL-CHICAGO, V68, P1404, DOI 10.1001/archneurol.2011.150
  16. Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215
  17. Goos JD, 2012, NEUROBIOL AGING, V33
  18. Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6
  19. Habert MO, 2011, NEUROBIOL AGING, V32, P15, DOI 10.1016/j.neurobiolaging.2009.01.013
  20. Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5
  21. Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70
  22. Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016
  23. Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277
  24. Jack CR, 2011, ALZHEIMERS DEMENT, V7, P474, DOI 10.1016/j.jalz.2011.04.007
  25. Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6
  26. Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004
  27. Jack CR, 2012, RADIOLOGY, V263, P343, DOI 10.1148/radiol.12110433
  28. Jagust William, 2004, NeuroRx, V1, P206, DOI 10.1007/BF03206604
  29. Josephs KA, 2007, NEUROBIOL AGING, V28, P1718, DOI 10.1016/j.neurobiolaging.2006.07.010
  30. Kadir A, 2011, BRAIN, V134, P301, DOI 10.1093/brain/awq349
  31. Kadir A, 2012, NEUROBIOL AGING, V33
  32. Kas A, 2011, BRAIN, V134, P1464, DOI 10.1093/brain/awr055
  33. Kas A, 2012, J NEUROL NEUROSUR PS, V83, P695, DOI 10.1136/jnnp-2012-302165
  34. Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009
  35. Koivunen J, 2011, NEUROLOGY, V76, P1085, DOI 10.1212/WNL.0b013e318212015e
  36. Krueger CE, 2010, ALZ DIS ASSOC DIS, V24, P43, DOI 10.1097/WAD.0b013e3181a6f101
  37. Lindberg O, 2012, J ALZHEIMERS DIS, V30, P355, DOI 10.3233/JAD-2012-112210
  38. Lo RY, 2011, ARCH NEUROL-CHICAGO, V68, P1257, DOI 10.1001/archneurol.2011.123
  39. McDonald CR, 2009, NEUROLOGY, V73, P457, DOI 10.1212/WNL.0b013e3181b16431
  40. McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1
  41. MCKHANN G, 1984, NEUROLOGY, V34, P939
  42. McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
  43. Mosconi L, 2012, NEUROBIOL AGING
  44. Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9
  45. Noble JM, 2009, INT REV NEUROBIOL, V84, P133, DOI 10.1016/S0074-7742(09)00407-3
  46. Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217
  47. Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564
  48. Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4
  49. Rabinovici GD, 2008, ANN NEUROL, V64, P388, DOI 10.1002/ana.21451
  50. Rabinovici GD, 2011, NEUROLOGY, V77, P2034, DOI 10.1212/WNL.0b013e31823b9c5e
  51. Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179
  52. Rodriguez MJ, 2012, ALZHEIMERS DEMENT, V8, P211, DOI 10.1016/j.jalz.2011.04.008
  53. Rollin-Sillaire A, 2012, J ALZHEIMERS DIS, V30, P833, DOI 10.3233/JAD-2012-111067
  54. Rosenbloom MH, 2011, NEUROLOGY, V76, P1789, DOI 10.1212/WNL.0b013e31821cccad
  55. Sabattoli F, 2008, NEUROIMAGE, V41, P699, DOI 10.1016/j.neuroimage.2008.02.060
  56. Sabuncu MR, 2011, ARCH NEUROL-CHICAGO, V68, P1040, DOI 10.1001/archneurol.2011.167
  57. Sarazin M, 2012, NEUROIMAG CLIN N AM, V22, P23, DOI 10.1016/j.nic.2011.11.004
  58. Sarazin M, 2010, J ALZHEIMERS DIS, V22, P285, DOI 10.3233/JAD-2010-091150
  59. Scholl M, 2011, NEUROBIOL AGING, V32, P1388, DOI 10.1016/j.neurobiolaging.2009.08.016
  60. Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225
  61. Vemuri P, 2008, NEUROIMAGE, V42, P559, DOI 10.1016/j.neuroimage.2008.05.012
  62. Villemagne VL, 2011, INT PSYCHOGERIATR, V23, pS41, DOI 10.1017/S1041610211000895
  63. Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516
  64. Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d
  65. Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010
  66. Wolk DA, 2011, ARCH NEUROL-CHICAGO, V68, P1398, DOI 10.1001/archneurol.2011.153
  67. Womack KB, 2011, ARCH NEUROL-CHICAGO, V68, P329, DOI 10.1001/archneurol.2010.295

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros